Correspondence Regarding: Atrial Fibrillation in the Intensive Care Setting

Malik A Candilio L Hausenloy DJ . Atrial fibrillation in the intensive care setting. JICS 2013;14: 141–49.

Rasmussen HS Thomsen PEB . The electrophysiologic effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle. Clin Cardiol 1989;12: 85–90.

Moran JL Gallagher J Peake SL . Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study. Crit Care Med 1995;23: 1816–24.

Ho KM Sheridan DJ Paterson T . Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta analysis. Heart 2007;93: 1433–40.

Sleeswijk ME Tulleken JE Van Noord T . Efficacy of magnesium-amiodarone step-up scheme in critically ill patients with new-onset atrial fibrillation: a prospective observational study. J Intensive Care Med 2008;23: 61–66.

Wu X Wang C Zhu J . Meta-analysis of randomized controlled trials on magnesium in addition to beta-blocker for prevention of postoperative atrial arrhythmias after coronary artery bypass grafting. BMC Cardiovasc Disorders 2013;13: 5.

Fawcett WJ Haxby EG Male DA . Magnesium: Physiology and pharmacology. Br J Anaes 1999;83: 302–20.

Balser JR Martinez EA Winters BD . Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology 1998;89: 1052–59.